Nuclear localization of cytokeratin 8 and the O-linked N -acetylglucosamine-containing Epitope H in epithelial cells of infiltrating ductal breast carcinomas: A combination of immunogold and EDTA regressive staining methods

Ultrastructural Pathology

Volumn 30, Issue 3, 2006, Pages 177-186

  Havaki, Sophia ^a   Voloudakis Baltatzis, Irene ^b   Goutas, Nikos ^a   Arvanitis, Leonidas D ^c   Vassilaros, Stamatis D ^d   Arvanitis, Dimitrios L ^c   Kittas, Christos ^a   Marinos, Evangelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d Prolipsis Breast Diagnostic Center   (Greece)

Author keywords

Cytokeratin 8; Double immunogold labeling; EDTA regressive staining method; Epitope H; Infiltrating ductal breast carcinoma; Nucleus

Indexed keywords

CELL NUCLEUS DNA; CYTOKERATIN 8; EPITOPE; GENE PRODUCT; MATRIX ATTACHMENT REGION BINDING PROTEIN; MYC PROTEIN; N ACETYLGLUCOSAMINE; POLYPEPTIDE; RIBONUCLEOPROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; FIBROADENOMA; GENE CLUSTER; GENETIC TRANSCRIPTION; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOGOLD LABELING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA PROCESSING; TUMOR BIOPSY; TUMOR CELL;

ACETYLGLUCOSAMINE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL NUCLEUS; EDETIC ACID; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MICROSCOPY, IMMUNOELECTRON; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 33745912993     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120600689806     Document Type: Article

References (65)

1. Parkin DM. International variation. Oncogene. 2004;23:6329-6340.
2. Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G. Tumours in Iceland, 10: malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations. APMIS. 1988;96:229-238.
3. Rosen PP. Invasive duct carcinoma and morphological prognostic markers. In: Rosen PP, ed. Breast Pathology. Philadelphia: Lippincott-Raven; 1997:275-293.
4. Ahmed A. Atlas of the Ultrastructure of Human Breast Diseases. London: Churchill-Livingstone; 1978.
5. Gallager SH. Pathologic types of breast cancer: their prognoses. Cancer. 1984;53:623-629.
6. Moll R, Krepler R, Franke WW. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation. 1983;23:256-269.
7. Osborn M, Weber K. Tumour diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983;48:372-394.
8. Quinlan RA, Schiller DL, Hatzfeld M, et al. Patterns of expression and organization of cytokeratin intermediate filaments. In: Wang E, Fishman D, Liem RRH, Sun T-T, eds. Intermediate Filaments. Ann NY Acad Sci. NY: NYAS; 1985;455:282-306.
9. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
10. Hembrough TA, Vasudevan J, Allietta MM, Glass II WF, Gonias SL. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci. 1995;108:1071-1082.
11. Hembrough TA, Li L, Gonias SL. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem. 1996;271:25684-25691.
12. Kralovich KR, Li L, Hembrough TA, Webb DJ, Karns LR, Gonias SL. Characterization of the binding sites for plasminogen and tissue-type plasminogen activator in cytokeratin 8 and cytokeratin 18. J Protein Chem. 1998;17:845-854.
13. Gonias SL, Hembrough TA, Sankovic M. Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells. Front Biosci. 2001;6:1403-1411.
14. Godfroid E, Geuskens M, Dupressoir T, Parent I, Szpirer C. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J Cell Sci. 1991;99:595-607.
15. Chan R, Rossitto PV, Edwards BF, Cardiff RD. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res. 1986;46:6353-6359.
16. Spencer VA, Coutts AS, Samuel SK, Murphy LC, Davie JR. Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem. 1998;273:29093-29097.
17. Havaki S, Dafni LJ, Sotiropoulou C, et al. Ultrastructural immunostaining of infiltrating ductal breast carcinomas with the monoclonal antibody H: a comparative study with cytokeratin 8. Ultrastruct Pathol. 2003;27:393-407.
18. Arvanitis DL, Kouklis P, Mori de Moro G, Goutas N, Kittas C, Szuchet S. Immunostaining of ductal breast carcinomas with the monoclonal antibody H. Oncol Rep. 1995;2:991-995.
19. Arvanitis DL, Stavridou AI, Mori de Moro G, Szuchet S. Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res. 2001;304:11-19.
20. Arvanitis DL, Arvanitis LD, Panourias IG, Kitsoulis P, Kanavaros P. The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas. Histol Histopathol. 2005;20:1057-1063.
21. Arvanitis DL, Arvanitis LD, Panourias IG, Kitsoulis P, Kanavaros P. Mitochondria-rich normal, metaplastic, and neoplastic cells show overexpression of the epitope H recognized by the monoclonal antibody H. Pathol Res Pract. 2005;201:319-324.
22. Chou C-F, Smith AJ, Omary MB. Characterization and dynamics of O-linked glycosylation of human cytokeratins 8 and 18. J Biol Chem. 1992;267:3901-3906.
23. Haltiwanger RS, Kelly WG, Roquemore EP, et al. Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic. Biochem Soc Trans. 1992;20:264-269.
24. Haltiwanger RS, Busby S, Grove K, et al. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation? Biochem Biophys Res Commun. 1997;231:237-242.
25. Hart GW. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem. 1997;66:315-335.
26. Zachara NE, Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev. 2002;102:431-438.
27. Chou TY, Dang CV, Hart GW. Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci USA. 1995;92:4417-4421.
28. Chou TY, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phopshorylation site and a mutational hot spot in lymphomas. J Biol Chem. 1995;270:18961-18965.
29. Medina L, Grove K, Haltiwanger RS. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology. 1998;8:383-391.
30. Chou TY, Hart GW. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc. Adv Exp Med Biol. 2001;491:413-418.
31. Hanover JA. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 2001;15:1865-1876.
32. Bernhard W. A new staining procedure for electron microscopical cytology. J Ultrastruct Res. 1969;27:250-265.
33. Lafarga M, Hervas JP, Santa-Cruz MC, Villegas J, Crespo D. The "accessory body" of Cajal in the neuronal nucleus: a light and electron microscopic approach. Anat Embryol. 1983;166:19-30.
34. Esponda P, Souto-Padron T, De Souza W. Fine structure and cytochemistry of the nucleus and the kinetoplast of epimastigotes of Trypanosoma cruzi. J Protozool. 1983;30:105-110.
35. Le Douarin N. Comparative ultrastructural study of the interphasic nucleus in the quail (Coturnix coturnix japonica) and the chicken (Gallus gallus) by the regressive EDTA staining method. C R Acad Sci Hebd Seances Acad Sci D. 1971;272:2334-2337.
36. Dardick I, Dardick AM, Caldwell DR, Jeans MT, Bladon T, Setterfield G. Non-Hodgkin's lymphoma classification: ultrastructural morphometric studies for the quantification of nuclear compartments in situ. Hum Pathol. 1985;10:1047-1060.
37. González-Melendi P, Testillano PS, Mena CG, Muller S, Raska I, Risueño MC. Histones and DNA ultrastructural distribution in plant cell nucleus: a combination of immunogold and cytochemical methods. Exp Cell Res. 1998;242:45-59.
38. Fakan S, Leser G, Martin TE. Ultrastructural distribution of nuclear ribonucleoproteins as visualized by immunocytochemistry in thin sections. J Cell Biol. 1984;98:358-363.
39. Pederson T. Thinking about a nuclear matrix. J Mol Biol. 1998;277:147-159.
40. Spector DL. Macromolecular domains within the cell nucleus. Annu Rev Biochem. 1993;9:265-315.
41. Bachellerie JP, Puvion E, Zalta JP. Ultrastructural organization and biochemical characterization of chromatin-RNA-protein complexes isolated from mammalian cell nuclei. Eur J Biochem. 1975;58:327-337.
42. Puvion E, Moyne G. Intranuclear migration of newly synthesized extranucleolar ribonucleoproteins: a high resolution quantitative autoradiographical and cytochemical study. Exp Cell Res. 1978;115:79-88.
43. Hendzel MJ, Kruhlak MJ, Bazett-Jones DP. Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation. Mol Biol Cell. 1998;9:2491-2507.
44. Misteli T, Spector, DL. The cellular organization of gene expression. Curr Opin Cell Biol. 1998;10:323-331.
45. Bloom HJG, Richardson HH. Histological grading and prognosis in breast cancer A study of 1409 cases of which 359 have been followed for fifteen years. Br J Cancer. 1957;11:359-377.
46. Causton B. The choice of resins for electron immunocytochemistry. In: Polak JM, Varndell IM, eds. Immunolabelling for Electron Microscopy. Amsterdam: Elsevier; 1984:29-36.
47. Polak JM, Van Noorden S. Post-embedding immunocytochemistry for the transmission electron microscope. In: Polak JM, Van Noorden S, eds. Introduction to Immunocytochemistry. Oxford, UK: Bios Scientific; 1997:81-89.
48. Komitowski DD, Hart MM, Janson CP. Chromatin organization and breast cancer prognosis. Cancer. 1993;72:1239-1246.
49. Spencer VA, Samuel SK, Davie JR. Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells. Cancer Res. 2001;61:1362-1366.
50. Djabali K. Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear periphery. Histol Histopathol. 1999;14:501-509.
51. Tolstonog GV, Sabasch M, Traub P. Cytoplasmic intermediate filaments are stably associated with nuclear matrices and potentially modulate their DNA-binding function. DNA Cell Biol. 2002;21:213-239.
52. Ward WS, Schmidt WN, Schmidt CA, Hnilica LS. Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1984;81:419-423.
53. Wang X, Tolstonog G, Shoeman RL, Traub P. Selective binding of specific mouse genomic DNA fragments by mouse vimentin filaments in vitro. DNA Cell Biol. 1996;15:209-225.
54. Wilson KL. The nuclear envelope, muscular dystrophy, and gene expression. Trends Cell Biol. 2000;10:125-129.
55. Chan JK, Park PC, De Boni U. Association of DNase sensitive chromatin domains with the nuclear periphery in 3T3 cells in vitro. Biochem Cell Biol. 2000;78:67-78.
56. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA. 1990;87:2319-2323.
57. Kelly WG, Hart GW. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell. 1989;57:243-251.
58. Soulard M, Della Valle V, Siomi MC, et al. hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acid Res. 1993;21:4210-4217.
59. Kelly WG, Dahmus ME, Hart GW. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem. 1993;268:10416-10424.
60. Jackson SP, Tjian R. Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc Natl Acad Sci USA. 1989;86:1781-1785.
61. Reason AJ, Morris HR, Panico M, et al. Localization of O-GlcNAc modification on the serum response transcription factor. J Biol Chem. 1992;267:16911-16921.
62. Samarina OP. hnRNP particles. BioEssays. 1996;18:595-601.
63. Weighardt F, Biamonti G, Riva S. The roles of heterogeneous nuclear ribonucleoprotein (hnRNP) in RNA metabolism. BioEssays. 1996;18:747-756.
64. Wei X, Somanathan S, Samarabandu J, Berezney R. Three-dimensional visualization of transcription sites and their association with splicing factor-rich nuclear speckles. J Cell Biol. 1999;146:543-558.
65. Spector D, Fu XD, Maniatis T. Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J. 1991;10:3467-3481.